Paxlovid gets closer to full approval
65 Articles
65 Articles
Paxlovid gets closer to full approval
Welcome to The Hill’s Health Care newsletter {beacon} Health Care Health Care The Big Story Paxlovid gets closer to full approval A panel of independent experts voted this week to recommend that Paxlovid, the COVID-19 medication made by Pfizer, be granted full approval by the Food and Drug Administration (FDA). © AP The FDA’s…
Pfizer's COVID Pill Paxlovid Inching Closer to Getting FDA Approval
An advisory committee from the U.S. Food and Drug Administration (FDA) has voted in favor of approving a new drug application for Pfizer’s COVID pill Paxlovid, even as potential drug interaction risks were highlighted during the committee meeting. Paxlovid is an oral antiviral pill that has been available for use in the United States since Dec. 22, 2021, under Emergency Use Authorization (EUA). In June 2022, Pfizer submitted an application for f…
Coverage Details
Bias Distribution
- 75% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage